TORONTO, May 25, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global medical cannabis leader expanding throughout Latin America and Europe, today announces that it will host a Conference Call on Tuesday, May 31, 2022 at 10:00 a.m. Eastern time to discuss its results for the first quarter ended March 31, 2022. The Company will press release its financial results prior to the Conference Call. These filings will be …
